Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

Journal of Leukocyte Biology

Volumn 82, Issue 4, 2007, Pages 887-893

  Rasmusson, Ida ^a,c   Uhlin, Michael ^a,b   Le Blanc, Katarina ^a,b   Levitsky, Victor ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activation; Alloantigen; EBV; Effector CD8 T cells; Marrow stromal cells

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; BONE MARROW CELL; CELL FUNCTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MESENCHYME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; STEM CELL; STROMA CELL; UPREGULATION;

ADULT; ALLELES; ANTIGENS, CD; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL LINE; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PEPTIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

HUMAN HERPESVIRUS 4;

EID: 34848851890     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0307140     Document Type: Article

References (48)

1. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., Dazzi, F. (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722-3729.
2. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., Gianni, A. M. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843.
3. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D., Jorgensen, C. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837-3844.
4. Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., Guinan, E. C. (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389-397.
5. Rasmusson, I., Ringden, O., Sundberg, B., Le Blanc, K. (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76, 1208-1213.
6. Aggarwal, S., Pittenger, M. F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822.
7. Rasmusson, I., Ringden, O., Sundberg, B., Le Blanc, K. (2005) Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. 305, 33-41.
8. Potian, J. A., Aviv, H., Ponzio, N. M., Harrison, J. S., Rameshwar, P. (2003) Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171, 3426-3434.
9. Walczak, H., Krammer, P. H. (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256, 58-66.
10. Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., Ringden, O. (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57, 11-20.
11. Zemmour, J., Little, A. M., Schendel, D. J., Parham, P. (1992) The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148, 1941-1948.
12. Zhang, Q. J., Gavioli, R., Klein, G., Masucci, M. G. (1993) An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sci. USA 90, 2217-2221.
13. De Campos-Lima, P. O., Levitsky, V., Brooks, J., Lee, S. P., Hu, L. F., Rickinson, A. B., Masucci, M. G. (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179, 1297-1305.
14. Rabin, H., Hopkins III, R. F., Ruscetti, F. W., Neubauer, R. H., Brown, R. L., Kawakami, T. G. (1981) Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127, 1852-1856.
15. Torsteinsdottir, S., Masucci, M. G., Ehlin-Henriksson, B., Brautbar, C., Ben Bassat, H., Klein, G., Klein, E. (1986) Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc. Natl. Acad. Sci. USA 83, 5620-5624.
16. Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., Rickinson, A. B. (1997) Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185, 1605-1617.
17. Le Gal, F. A., Riteau, B., Sedlik, C., Khalil-Daher, I., Menier, C., Dausset, J., Guillet, J. G., Carosella, E. D., Rouas-Freiss, N. (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11, 1351-1356.
18. Malmberg, K. J., Levitsky, V., Norell, H., de Matos, C. T., Carlsten, M., Schedvins, K., Rabbani, H., Moretta, A., Soderstrom, K., Levitskaya, J., Kiessling, R. (2002) IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J. Clin. Invest. 110, 1515-1523.
19. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., McMichael, A. J. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
20. Adrian Cabestre, F., Moreau, P., Riteau, B., Ibrahim, E. C., Le Danff, C., Dausset, J., Rouas-Freiss, N., Carosella, E. D., Paul, P. (1999) HLA-G expression in human melanoma cells: protection from NK cytolysis. J. Reprod. Immunol. 43, 183-193.
21. Valitutti, S., Muller, S., Dessing, M., Lanzavecchia, A. (1996) Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183, 1917-1921.
22. Maitra, B., Szekely, E., Gjini, K., Laughlin, M. J., Dennis, J., Haynesworth, S. E., Koc, O. N. (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33, 597-604.
23. Klyushnenkova, E., Mosca, J. D., Zernetkina, V., Majumdar, M. K., Beggs, K. J., Simonetti, D. W., Deans, R. J., McIntosh, K. R. (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12, 47-57.
24. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., Ringden, O. (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31, 890-896.
25. Angoulvant, D., Clerc, A., Benchalal, S., Galambrun, C., Farre, A., Bertrand, Y., Eljaafari, A. (2004) Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology 41, 469-476.
26. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., Rachmilewitz, J. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214-2219.
27. Le Blanc, K., Rasmusson, I., Gotherstrom, C., Seidel, C., Sundberg, B., Sundin, M., Rosendahl, K., Tammik, C., Ringden, O. (2004) Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand. J. Immunol. 60, 307-315.
28. Groh, M. E., Maitra, B., Szekely, E., Koc, O. N. (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 33, 928-934.
29. Uhlin, M., Sandalova, E., Masucci, M. G., Levitsky, V. (2005) Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes. Eur. J. Immunol. 35, 2929-2939.
30. Uhlin, M., Masucci, M. G., Levitsky, V. (2005) Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 102, 9264-9269.
31. Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A., Hoffman, R. (2003) Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101, 2999-3001.
32. Kraitchman, D. L., Heldman, A. W., Atalar, E., Amado, L. C., Martin, B. J., Pittenger, M. F., Hare, J. M., Bulte, J. W. (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293.
33. Hill, J. M., Dick, A. J., Raman, V. K., Thompson, R. B., Yu, Z. X., Hinds, K. A., Pessanha, B. S., Guttman, M. A., Varney, T. R., Martin, B. J., Dunbar, C. E., McVeigh, E. R., Lederman, R. J. (2003) Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108, 1009-1014.
34. Pochampally, R. R., Neville, B. T., Schwarz, E. J., Li, M. M., Prockop, D. J. (2004) Rat adult stem cells (marrow stromal cells) engraft and differentiate in chick embryos without evidence of cell fusion. Proc. Natl. Acad. Sci. USA 101, 9282-9285.
35. Fouillard, L., Bensidhoum, M., Bories, D., Bonte, H., Lopez, M., Moseley, A. M., Smith, A., Lesage, S., Beaujean, F., Thierry, D., Gourmelon, P., Najman, A., Gorin, N. C. (2003) Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 17, 474-476.
36. Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., Marschall, H. U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L., Le Blanc, K. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390-1397.
37. Le Blanc, K., Gotherstrom, C., Ringden, O., Hassan, M., McMahon, R., Horwitz, E., Anneren, G., Axelsson, O., Nunn, J., Ewald, U., Norden-Lindeberg, S., Jansson, M., Dalton, A., Astrom, E., Westgren, M. (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79, 1607-1614.
38. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
39. Chung, N. G., Jeong, D. C., Park, S. J., Choi, B. O., Cho, B., Kim, H. K., Chun, C. S., Won, J. H., Han, C. W. (2004) Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int. J. Hematol. 80, 370-376.
40. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., Mancardi, G., Uccelli, A. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755-1761.
41. Gerdoni, E., Gallo, B., Casazza, S., Musio, S., Bonanni, I., Pedemonte, E., Mantegazza, R., Frassoni, F., Mancardi, G., Pedotti, R., Uccelli, A. (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61, 219-227.
42. Sudres, M., Norol, F., Trenado, A., Gregoire, S., Charlotte, F., Levacher, B., Lataillade, J. J., Bourin, P., Holy, X., Vernant, J. P., Klatzmann, D., Cohen, J. L. (2006) Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J. Immunol. 176, 7761-7767.
43. Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S., Galipeau, J. (2005) Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106, 4057-4065.
44. Grinnemo, K. H., Mansson, A., Dellgren, G., Klingberg, D., Wardell, E., Drvota, V., Tammik, C., Holgersson, J., Ringden, O., Sylven, C., Le Blanc, K. (2004) Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 127, 1293-1300.
45. Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G., Willemze, R., Fibbe, W. E. (2006) Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108, 2114-2120.
46. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., Hoffman, R. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48.
47. Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Ibatici, A., Piaggio, G., Pozzi, S., Frassoni, F., Locatelli, F. (2005) Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90, 516-525.
48. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., Dazzi, F. (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821-2827.